Research programme: immuno inflammatory disease therapeutics - Iconic therapeutics
Latest Information Update: 21 Nov 2023
Price :
$50 *
At a glance
- Originator Iconic Therapeutics
- Class Monoclonal antibodies
- Mechanism of Action Thrombin modulators; Thromboplastin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders; Inflammation
Most Recent Events
- 19 Oct 2023 Preclinical trials in Inflammation in USA (Parenteral)
- 19 Oct 2023 Preclinical trials in Autoimmune disorders in USA (Parenteral) (Iconic therapeutics pipeline; October 2023)